Steward Partners Investment Advisory, LLC Summit Therapeutics Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 2,503 shares of SMMT stock, worth $51,787. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,503
Previous 1,603
56.14%
Holding current value
$51,787
Previous $35,000
25.71%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SMMT
# of Institutions
233Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$505 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$241 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$163 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$136 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$116 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.16B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...